Aphria Inc.

+$0.00 (+0.0%)
Closing price May 7, 2021
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Caterpillar, Coca-Cola, Deere, MongoDB and StoneCo.
A few interesting earnings reports remain before a new round of earnings seasons begins next week. Here are three due out Friday and Monday.
The New York state legislature has approved a bill legalizing marijuana in the state and the governor has said he will sign it. Pot stocks are high on the news.
When one of the biggest and most populated states decides it is time to legalize pot, it is also time for investors to look at the top stocks in the industry again. Many of them have backed up...
In addition to rising hopes for a change in U.S. law removing marijuana from a list of dangerous drugs, a swarm of retail investors has been taking aim at pot stock short sellers. Here's how that's...
Top analyst calls seen Friday afternoon were on AstraZeneca, Foot Locker, PayPal, Tesla, Yeti and more.
Marijuana growers Aphria and Tilray have announced a reverse merger that will create the world's largest cannabis company measured by revenue.
Large marijuana stocks have risen sharply since the U.S. elections early in November. The increase is not based so much on the results as on what could happen next.
Late last week, some top pot stocks rallied. We screened the 24/7 Wall St. research database looking for marijuana stocks that could offer investors some huge returns over the next year or so and...
Marijuana stocks got hammered on Wednesday but came roaring back Thursday. What changed?
The marijuana industry was rewarded with some big wins on election night, but the top cannabis stocks didn't show it. These four pot stocks look like solid ideas now for patient, aggressive growth...
The upcoming election could give the marijuana industry and the movement to legalization a huge boost. While the dramatic moves some top pot stocks made a few years back may be history, these four...
Robinhood has become the dominant discount brokerage platform over the last year. It had 4.3 million average revenue trades in June, which is a critical metric in the industry. This is higher than...
A recent final ruling from the U.S. Drug Enforcement Administration has cast doubt on the legality of some non-psychoactive products derived from the hemp.
These five companies are likely to survive the current troubles and their stocks could very well offer patient investors some huge returns over the next year or so.